# ChatGPT Review: `gen_indication_endpoint_target` Phase 2

- Review time: 2026-08-01 18:13 EDT
- Reviewer: ChatGPT, `GitHub PR 信息` conversation
- GitHub source: selected through the chat `+` menu
- PR: https://github.com/leezx/StelligenOS/pull/20
- Branch: `task_20260801_gen-iet-phase2-clinical-frame`
- Reviewed HEAD: `73d4fcd`
- Base: `task_20260801_gen-iet-phase1-contracts`
- Review scope: Phase 2 T0-T1 Clinical Frame Pipeline contract-only diff

## Submitted Review Scope

ChatGPT was asked to review only the current PR diff, Phase 2 report, manifest,
handoff, migration log, worklog, tests, and validation metadata. The request
explicitly excluded Phase 3, PR #19, unrelated refactors, real data execution,
and target generation.

## Decision

`APPROVE`

ChatGPT response:

> Phase 2 审核通过，可以进入 Phase 3

No blocking findings were reported. The approval confirms that the current
Phase 2 scope may proceed to Phase 3, without approving Phase 3 implementation
or real asset generation itself.

## Reviewed Boundary

- External-only request/result references and positive candidate budget.
- No local data read, T0/T1 execution, ClinicalFrame/Evidence/TargetCandidate
  creation, database, cache, result persistence, weights, runner, or new Gate.
- Phase 2 report, manifest, handoff, worklog, PR description, 58 tests,
  repository boundary check, and `git diff --check` were included in scope.

## Next Gate

Phase 3 may begin from the approved Phase 2 tip on a new task branch. Phase 3
must receive its own GitHub PR and ChatGPT review before any subsequent phase.
